documents: FDA-2016-P-0159-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-P-0159-0004 | FDA | FDA-2016-P-0159 | Procedures for Class II Device Exemptions from Premarket Notification, Guidance for Industry and CDRH Staff re Medical Devices; Exemption From Premarket Notification: Method, Metallic Reduction, Glucose (Urinary, Non-Quantitative) Test System in a Reagent Tablet Format | Supporting & Related Material | Background Material | 2016-03-24T04:00:00Z | 2016 | 3 | 2016-03-28T19:32:37Z | 0 | 0 | 0900006481edd298 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref